Not available
Quote | Pain Therapeutics Inc. (NASDAQ:PTIE)
Last: | $ |
---|---|
Change Percent: | 6.90% |
Open: | $1.19 |
Close: | $1.24 |
High: | $1.2699 |
Low: | $1.18 |
Volume: | 294,506 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Pain Therapeutics Inc. (NASDAQ:PTIE)
AUSTIN, Texas, March 27, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a drug development company, announced a company name change to Cassava Sciences, Inc., effective immediately. The new name was chosen to better reflect the Company’s strategic focus on ...
Privately held Purdue Pharma LP has agreed to pay the state of Oklahoma $270M to settle litigation from the AG's office over its role in the opioid crisis there. More news on: Endo International plc, INSYS Therapeutics, Inc., Titan Pharmaceuticals, Inc., Healthcare stocks news, Stocks on...
Message Board Posts | Pain Therapeutics Inc. (NASDAQ:PTIE)
Subject | By | Source | When |
---|---|---|---|
May 2023 Corp Presentation: | FooBarAndGrill | investorshub | 05/01/2023 2:21:06 PM |
Enrollment rate: ~125/mo. | FooBarAndGrill | investorshub | 05/01/2023 2:18:51 PM |
$SAVA Patent application: SavaDX | FooBarAndGrill | investorshub | 05/01/2023 11:31:54 AM |
Thanks for the updates Foobar. | runncoach | investorshub | 04/27/2023 8:04:12 PM |
Judge stated 2-3 weeks for the dismissal decision. | FooBarAndGrill | investorshub | 04/27/2023 7:19:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Pain Therapeutics Inc. Company Name:
PTIE Stock Symbol:
NASDAQ Market:
Pain Therapeutics Inc. Website:
AUSTIN, Texas, March 27, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a drug development company, announced a company name change to Cassava Sciences, Inc., effective immediately. The new name was chosen to better reflect the Company’s strategic focus on ...
AUSTIN, Texas, March 25, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE) today reported financial results for the year ended December 31, 2018. Net loss in 2018 was $6.6 million, or $0.61 per share, compared to a net loss in 2017 of $11.9 million, or $1.82 per share. Cash us...
AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a clinical-stage drug development company, today announced feedback from a meeting held January 31, 2019 with the U.S. Food and Drug Administration (FDA) regarding the drug candidate, REMOXY ER. R...